Venturi Wealth Management LLC Acquires 2,770 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Venturi Wealth Management LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 9.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,753 shares of the healthcare conglomerate’s stock after buying an additional 2,770 shares during the quarter. Venturi Wealth Management LLC’s holdings in UnitedHealth Group were worth $16,063,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Fortis Group Advisors LLC boosted its position in UnitedHealth Group by 1.0% during the 4th quarter. Fortis Group Advisors LLC now owns 6,042 shares of the healthcare conglomerate’s stock worth $3,056,000 after acquiring an additional 57 shares during the last quarter. Pittenger & Anderson Inc. boosted its holdings in UnitedHealth Group by 0.3% during the fourth quarter. Pittenger & Anderson Inc. now owns 42,634 shares of the healthcare conglomerate’s stock worth $21,567,000 after purchasing an additional 136 shares during the last quarter. Human Investing LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $138,000. NTV Asset Management LLC boosted its stake in shares of UnitedHealth Group by 12.2% during the 4th quarter. NTV Asset Management LLC now owns 443 shares of the healthcare conglomerate’s stock worth $224,000 after buying an additional 48 shares during the last quarter. Finally, KLCM Advisors Inc. increased its position in shares of UnitedHealth Group by 1.6% in the fourth quarter. KLCM Advisors Inc. now owns 3,243 shares of the healthcare conglomerate’s stock valued at $1,641,000 after acquiring an additional 50 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 1.4 %

NYSE UNH opened at $523.48 on Tuesday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The business has a fifty day moving average price of $523.11 and a two-hundred day moving average price of $563.00. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market capitalization of $481.75 billion, a PE ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $5.83 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. KeyCorp reiterated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Barclays decreased their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.